# 1. Financial Performance ## A. Key Figures * **Total Income:** **₹650 Cr** Q2 FY26 (+24%) * **PAT:** **₹51 Cr** Q2 FY26 (+14%) · **7.9% margin** * Gross Debt: ₹405 Cr (Sep 2025) · 0.22x gross debt-to-equity, 0.11x net debt-to-equity * **Cash Balance:** **₹65–70 Cr** maintained · **₹240 Cr** fund-based limit ## B. Revenue Growth * **Record Momentum:** Q2 FY26 marked the company’s highest-ever quarterly performance, reflecting strong execution despite monsoon headwinds and prior accounting disruptions. * **Catch-Up Effect:** Revenue recovery follows a two-quarter panning out of prior accounting changes, with new projects (IIT, Downtown) expected to contribute from Q4 onward. * **Project-Specific Visibility:** Signature Global to contribute ~**₹150 Cr** this year; minimal revenue so far from Indus and NBCC, with normalization expected. * **Scaling Trajectory:** Revenues have grown from ₹500 Cr to over ₹800 Cr post-IPO, with **11,000 Cr** in cumulative revenue from core operations. ## C. Profit Margins * **Margin Resilience:** EBITDA and PAT margins held firm at 8% and 9% despite a ~500 bps gross margin decline, now stabilized under finalized accounting policies. * **Structural Drivers:** Higher-margin EPC and super high-rise projects are key profitability levers due to engineering control and premium pricing. * **Cost Tailwinds:** Lower financing costs expected from reduced Avendus debt (down 45%), lower bank guarantee commissions, and improved top-line leverage. ## D. Balance Sheet * **Deleveraging Underway:** Gross debt reduced to ₹405 Cr, with Avendus loan down to ₹57 Cr and further repayment of ₹14 Cr scheduled this quarter. * **Credit Capacity Expanded:** Total consortium limits set at **₹1,420 Cr** for Aug 2025–Jul 2026; new banks onboarded, though SBI sanction pending—full tie-up confirmed. * **Liquidity Buffer:** ~**₹300 Cr** in unutilized non-fund-based limits available, plus **₹150 Cr** in project-specific SBI limits for future use. * **Asset Base:** Net block of assets at **₹425–430 Cr** (gross ₹800 Cr), supporting operational scale. ## E. Cash Flow * **Working Capital Improvement:** Debtor levels reduced by **₹90 Cr**, with debtor days down 22 days YTD and a 45-day reduction target, boosting cash conversion. * **Cash Flow Levers:** Design-build projects now reducing contract assets and working capital intensity; asset monetization ongoing with **₹30 Cr** expected this quarter. * **Interest Cost Trajectory:** First-half FY26 interest at **₹47 Cr**, down sharply from full-year FY25’s ₹93 Cr, with further decline expected in H2. --- # 2. Order Book & Inflows ## A. Key Figures * **YTD Bookings:** **₹3,464 Cr** (near full-year target) * **Standalone Order Book:** **₹11,991 Cr** (60% public, 40% private) * **Order Inflow (FY):** **₹3,500 Cr** (target met) * **CIDCO Projects:** **~₹2,600 Cr** (first six locations) · **+₹300 Cr** expected H2 · **₹720 Cr** to be billed next FY * **Seventh CIDCO Location:** **~₹2,000 Cr** executable work (42-month execution) ## B. Order Book Dynamics * **Strong Momentum:** Robust year-to-date bookings achieved ahead of schedule, driven by **repeat marquee clients** and **strategic new wins**. * **Execution Scalability:** Subcontractor capacity supports **35% of handed-over work**, with full recognition of the **entire MHADA project** expected by early next fiscal. * **Project Quality Focus:** Company now selectively pursuing new orders, prioritizing **client quality over volume**, even after exceeding annual targets. ## C. Market Mix & Strategic Shifts * **Improved Private-Sector Penetration:** Order mix shifting toward private sector due to **large-ticket private awards**, with expected public-private split of **55:45 to 60:40**. * **Larger Project Profile:** Recent wins from Uptown, NBCC, and IIT Bombay reflect a strategic pivot to **projects exceeding ₹500 Cr**, with several in the **₹1,000–1,500 Cr range**. ## D. Joint Ventures & Future Visibility * **JV Revenue Inflection Expected:** H2 to see improved recoveries and profits from JVs, with **Bhandup Hospital Project** contributing in Q4 and **Mara JV** gaining momentum next fiscal. * **Upside Beyond Guidance:** Seventh CIDCO location to add **~₹2,000 Cr** of executable work in Q4—**not included in current revenue outlook**—providing embedded growth optionality. --- # 3. Project Execution & Progress ## A. Key Figures * **MHADA Rehab Towers:** **25 of 34** handed over (~75% complete) · **5 more expected by early Dec-25** * **Execution Pace:** **₹1,200 Cr** in H1 · **₹240 Cr** executed in October · **₹725 Cr planned in Q3** · **₹850 Cr in Q4** to meet **₹2,800 Cr target** * **Signature Global Revenue:** **₹70 Cr** from Phase-I · **monthly billing > ₹10 Cr** ## B. Key Project Status * **MHADA Momentum:** Rehab tower delivery on track with 75% already handed over; structural work on sale component set to begin in Jan–Feb, following design finalization and piling progress. * **Commercial Tower Greenlight:** 66-floor commercial tower approved this week, with land clearance nearly complete and design phase targeting Q4 completion. * **Accelerated Timelines:** Government-mandated execution periods now reduced to **30 months** from five years, reflecting adoption of faster construction technologies. * **IIT Bombay Project:** Design phase ongoing, with approval and commencement expected by **end-December** and **Q4 execution start**, respectively, under a 24+6 month timeline. * **Super High-Rise Leadership:** Constructing **India’s tallest building (320m)** via JV with Tata Projects, reinforcing top-three national positioning in super high-rise segment. ## C. CIDCO Handover * **Near-Term Deliveries:** Two CIDCO sites to be handed over by **12 December**, with remaining four locations scheduled in phases through FY26–27 and FY27–28. --- # 4. Segment & Client Mix ## A. Key Figures * **Order Book Split:** **55–56% EPC** · **43–44% BOP** * **Monthly Billing:** **₹20+ Cr** (Maldives project) · **Over ₹22 Cr** (Raymond) * **Outstanding Receivables:** **₹40 Cr** (NBCC project) ## B. EPC vs BOP Split * **EPC-Dominated Pipeline:** Order book skewed toward EPC, reflecting shift in government procurement toward turnkey contracts, while private sector remains predominantly BOP. * **Strategic Project Access:** Company is positioned to win large-scale EPC mandates, including **EXIM Bank-funded opportunities** in the Maldives and projects exceeding **₹700–1,000 Cr**. ## C. Top Clients * **Diversified Private Client Base:** Maintains active relationships with **10–12 private clients**, including marquee names like Raymond, Godrej, and Hinduja, with recent addition of **IIT Bombay** for a specialized drone research center. * **Design-Build Complexity:** Projects like Indus are integrated design-build, limiting revenue visibility, while others such as Raymond contribute **robust, predictable monthly cash flows**. ## D. Government Exposure * **Concentrated Public Sector Revenue:** Nearly half of future revenues tied to **three key Maharashtra agencies**—CIDCO, MHADA, and MCGM—selected for their financial reliability and self-funding capacity. * **Controlled Central Government Engagement:** Active in central projects via PSUs like NBCC under **Supreme Court oversight**, with receivables managed within expected thresholds. --- # 5. Capacity & Labor ## A. Key Figures * **Workforce:** **12,000+** current workmen · targeting **14,000–15,000** * Net Asset Turnover: **5.4x** core assets (H1 FY26) · up from 2–5x, targeting **6x** by year-end * **Revenue (Signature Global Phase-I):** **₹70 Cr** ## B. Workforce Strategy * **Scaled Labor Mobilization:** Workforce expansion underway to meet rising project demands, enabled by a dedicated 24/7 Labor Resource Department for recruitment and retention. * **Labor Optimization:** Proactive investment in improved worker amenities and automation to mitigate labor constraints while maintaining execution pace. ## C. Asset Utilization & CAPEX * **High Asset Efficiency:** Significant improvement in asset turnover driven by operational discipline and a single-segment focus that minimizes idle equipment and HR complexity. * **Targeted CAPEX Deployment:** Second-half spending to remain aligned with Phase-I levels, with strategic allocation toward aluminum formwork for NBCC and Signature Global projects. * **Revenue Momentum:** Signature Global Phase-II has commenced, with revenue generation expected to begin next month, building on Phase-I’s strong performance. --- # 6. Risks & Payment Delays ## A. Key Figures * Long Outstanding Receivables: ₹63 Cr (Q1) → ₹55 Cr (Q2) (-₹8.69 Cr recovery) * Recovery & Asset Sales: ₹8.69 Cr recovered in Q2 · ₹31 Cr from property sales expected in current quarter * Pending Receivables: ₹45 Cr from JJ Hospital (PWD Maharashtra), 50% expected by December * **Receivables Trend:** ₹500 Cr (Mar-24) → ₹1,151 Cr (Mar-25) · ↓₹100 Cr in first half of current FY * **Debtor Days:** ↓21 days in H1 FY26 · Target: ↓20–25 days in H2 · Full-year goal: ↓60 days ## B. Receivables Risk * **One-Time Recovery Clarity:** ₹69 Cr recovery from Neelkanth was realization of a slow-moving asset, not a bad debt reversal, hence excluded from other income. * **Working Capital Improvement:** Sharp ₹100 Cr reduction in receivables and **21-day drop in debtor days** signal effective collections and reversal of prior EPC-driven buildup. * **EPC Payment Impact:** Elevated receivables in FY25 stemmed from **milestone-based EPC contracts**, not credit risk, with normalization underway. * **Collateral Coverage:** Auditors flagged ₹55 Cr as bad debt, but company holds **fully written-off properties worth ₹200 Cr** as underlying security. * **JJ Hospital Delays:** Only delayed project; **50% of ₹45 Cr pending receivables** expected by December, with **monthly billing of ₹15 Cr** and ~90-day average aging. ## C. Government Funding * **Funding Discipline:** All Maharashtra projects are fully funded; new bids restricted to **central and fully funded state agencies** to avoid fiscal risk. * **Payment Delays Due to Liquidity:** Government clients (except PWD Maharashtra) face fund shortages, leaving **October certified bills unpaid**, though expected imminently. * **Strategic Advocacy:** JJ Hospital project recognized as **national priority**; fund allocation secured via engagement with Medical Education Department. ## D. Labor Availability * **Sector-Wide Labor Shortage:** Skilled workforce scarcity impacting Capacit'e and peers due to **competition from UAE, Middle East, and Eastern Europe**. --- # 7. Guidance & Outlook ## A. Key Figures * **Revenue Guidance:** **₹2,800 Cr** for current year (on track) · **₹4,000 Cr** target by FY28 (~20–23% CAGR) * **MHADA Revenue:** **>₹1,000 Cr** expected in FY27 (near doubling) * EBITDA Margin Guidance: 16.5%–17.5% for FY (ex-other income) · 16.8% achieved in H1 ## B. Revenue Target * **Growth Trajectory:** Revenue on track to meet ₹2,800 Cr target, with **strong execution momentum** over the past six to seven quarters and PAT trending at the higher end of guidance. * **Long-Term Scaling:** FY28 ₹4,000 Cr revenue target underpinned by **robust project pipeline and balance sheet strength**, with profitability expected to outpace top-line growth. * **SPV-Level Momentum:** MHADA project revenues poised for **near doubling in FY27**, reflecting accelerated execution and visibility in government-backed infrastructure. ## C. Margin Guidance * **Core Margin Clarity:** EBITDA guidance maintained at 5%–5%, now **exclusively reflecting core operations** after excluding other income for improved transparency. * **H1 Outperformance:** Strong first-half EBITDA at **8%** provides cushion toward full-year target, with management confident of landing at the **upper end of the range**. * **Structural Edge:** Positioned at the **upper end of industry margin benchmarks**, with focus on **alternative technologies** rather than diversification to sustain profitability. ## D. Debt Reduction * **Balance Sheet Improvement:** Confident path to **lower gross debt and reduced debtor levels**, supported by asset monetization and improved collections. * **Funding Resilience:** Past cash flow challenges deemed avoidable going forward due to **enhanced funding safeguards and self-sustaining cash flows**. * **Declining Finance Costs:** Despite higher activity, **absolute interest expenses declining year-on-year**, with FY27 forecast at ₹85 Cr, reinforcing financial discipline.